TMO Thermo Fisher Scientific Inc

Price (delayed)

$573.63

Market cap

$224.98B

P/E Ratio

31.97

Dividend/share

$1.2

EPS

$17.94

Enterprise value

$251.22B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
The company's equity rose by 13% YoY and by 3% QoQ
Thermo Fisher Scientific's revenue has increased by 13% YoY and by 3.1% from the previous quarter
Thermo Fisher Scientific's quick ratio has plunged by 58% YoY but it has increased by 8% from the previous quarter
The debt has increased by 34% YoY but it has decreased by 3.6% QoQ
Thermo Fisher Scientific's net income has decreased by 18% YoY and by 5% from the previous quarter
TMO's EPS is down by 17% year-on-year and by 5% since the previous quarter

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
392.2M
Market cap
$224.98B
Enterprise value
$251.22B
Valuations
Price to earnings (P/E)
31.97
Price to book (P/B)
5.16
Price to sales (P/S)
5.09
EV/EBIT
29.97
EV/EBITDA
21.66
EV/Sales
5.69
Earnings
Revenue
$44.17B
EBIT
$8.38B
EBITDA
$11.6B
Free cash flow
$5.63B
Per share
EPS
$17.94
Free cash flow per share
$14.36
Book value per share
$111.15
Revenue per share
$112.67
TBVPS
$82.23
Balance sheet
Total assets
$90.54B
Total liabilities
$46.93B
Debt
$29.16B
Equity
$43.55B
Working capital
$8.18B
Liquidity
Debt to equity
0.67
Current ratio
1.74
Quick ratio
0.95
Net debt/EBITDA
2.26
Margins
EBITDA margin
26.3%
Gross margin
44.4%
Net margin
15.9%
Operating margin
20.5%
Efficiency
Return on assets
7.6%
Return on equity
16.8%
Return on invested capital
17.1%
Return on capital employed
10.6%
Return on sales
19%
Dividend
Dividend yield
0.21%
DPS
$1.2
Payout ratio
6.7%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
-0.65%
1 week
-3.37%
1 month
5.17%
1 year
3.59%
YTD
4.17%
QTD
4.17%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$44.17B
Gross profit
$19.62B
Operating income
$9.07B
Net income
$7.03B
Gross margin
44.4%
Net margin
15.9%
The net margin has decreased by 27% YoY and by 9% QoQ
Thermo Fisher Scientific's operating margin has decreased by 24% YoY and by 9% from the previous quarter
Thermo Fisher Scientific's net income has decreased by 18% YoY and by 5% from the previous quarter
The operating income has contracted by 14% YoY and by 6% from the previous quarter

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
31.97
P/B
5.16
P/S
5.09
EV/EBIT
29.97
EV/EBITDA
21.66
EV/Sales
5.69
TMO's EPS is down by 17% year-on-year and by 5% since the previous quarter
The stock's price to earnings (P/E) is 4.8% more than its last 4 quarters average of 30.5
The company's equity rose by 13% YoY and by 3% QoQ
The P/B is 12% above the 5-year quarterly average of 4.6 but 4.4% below the last 4 quarters average of 5.4
Thermo Fisher Scientific's revenue has increased by 13% YoY and by 3.1% from the previous quarter
The P/S is 7% below the last 4 quarters average of 5.5 but 3.9% above the 5-year quarterly average of 4.9

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 45% year-on-year and by 12% since the previous quarter
TMO's ROA is down by 39% YoY and by 11% from the previous quarter
The ROE has contracted by 29% YoY and by 8% from the previous quarter
TMO's ROS is down by 29% year-on-year and by 10% since the previous quarter

Dividends

What is TMO's dividend history
DPS
$1.2
Dividend yield
0.21%
Payout ratio
6.7%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 93% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has plunged by 58% YoY but it has increased by 8% from the previous quarter
The current ratio has declined by 45% year-on-year but it has increased by 5% since the previous quarter
The debt is 33% lower than the equity
The debt has increased by 34% YoY but it has decreased by 3.6% QoQ
Thermo Fisher Scientific's debt to equity has increased by 20% YoY but it has decreased by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.